As you can see on the presented chart first goes Gilead Sciences, USA Pharmaceutical Giant which we see as the main sorce of income and R&D of USA Pharmaceuticals Industry. Main levels are 82.50, 79.00, 73.50, 69.00. Second is Pfizer, Europe Pharmaceutical giant, main levels are 54.50, 46.50, 28.50. Third is Merck, based, again, in Europe, main levels are 115.00, 80.50. Fourth is Bayer, a multinational Pharmaceutical Giant. Fifth is Life, biopharm company from Russia, main levels are, 9.00, 7.25, 4.70. Sixth is Diod, experimental and natural medicine company, main levels are 24.00, 15.50.
We see a possibility of strong profits in coming quarters, due to the winter season and new R&D activities. Wee see these companies as a good opportunity for a risk oriented investor to hold for about twelve to twenty four months.
We see a possibility of strong profits in coming quarters, due to the winter season and new R&D activities. Wee see these companies as a good opportunity for a risk oriented investor to hold for about twelve to twenty four months.
הערה:
Remember i am not your financial advisor. You are at your own risk. This is not an investment advice.